Needs by area

Needs by area

Choose your area of concern

Cheekbones

Cheekbones

Cheekbones

Effects of ageing

Descent of cheek fat pads and loss of volume as a result of gravity3,5,12

Specific concern

Visible creases between sinking fat pads,2 giving a sad, bitter and tired look6

Expectations from aesthetic treatment

Adding of definition and sculpting for a younger-looking, more beautiful appearance2,3,6

No unsightly bloating (chipmunk look) of the face6
Natural plumping and lifting effect6
Long-lasting results7 with minimum side effects7,8

Treatment

TEOSYAL® PURESENSE ULTRA DEEP

TEOSYAL® PURESENSE ULTRA DEEP9

 

Cheeks

Cheeks

Cheeks

Effects of ageing

Loss of underlying fat, redistribution of fat3,12

Specific concern

Hollowing, creases and depressions creating a worn-out look2,6

Expectations from aesthetic treatment

Plumping out of hollowed area and rejuvenating the appearance2,3

Preserved facial dynamism6

Natural lifting effect & long-lasting results7 with minimum side effects7,8

Treatment

TEOSYAL RHA® 4

TEOSYAL RHA® 411

Smile/laugh lines

Nasolabial folds

Smile/laugh lines

Effects of ageing

Loss of underlying fat, skin elasticity and repeated muscle movements2,4,6

Specific concern

Asymmetries, deeper folds and sagging skin, giving a sad and tired look2,6

Expectations from aesthetic treatment

Removal of asymmetries and tightening of skin, filling in of pronounced creases2

Preserved facial dynamism (no frozen grin)6

Natural-looking rejuvenation6,7 
Long-lasting results7 with minimum side effects7,8

Treatment

TEOSYAL RHA® 3

TEOSYAL RHA® 310

References

TEOSYAL RHA® 3, TEOSYAL RHA® 4 and TEOSYAL® PURESENSE ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. TEOSYAL® PURESENSE Ultra Deep exist also without lidocaine : TEOSYAL® ULTRA DEEP. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.

Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas).

General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.

Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.

Please consult your physician or pharmacist for more information.

Please refer to instructions for use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effects or any claim as soon as possible to the following address: medical@teoxane.com.

  1. Emre IE, Cakmak O. Ageing face, an overview – Aetiology, assessment and management. Otorhinolaryngol. 2013;6(3):160-6.
  2. Bass LS. Injectable filler techniques for facial rejuvenation, volumization, and augmentation. Facial Plast Surg Clin North Am. 2015;23(4):479-88.
  3. Gutowski KA. Hyaluronic acid fillers: science and clinical uses. Clin Plast Surg. 2016;43(3):489-96.
  4. Coleman SR, Grover R. The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J. 2006;26(1S):S4-9.
  5. Pao KY, Mancini R. Nonsurgical periocular rejuvenation: advanced cosmetic uses of neuromodulators and fillers. Curr Opin Ophthalmol. 2014;25(5):461-9.
  6. Michaud T, Gassia V, Belhaouari L. Facial dynamics and emotional expressions in facial aging treatments. J Cosmet Dermatol. 2015;14(1):9-21.
  7. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging. 2007;2(3):369-76
  8. TEOXANE DoF 207414-E_ADV-TEOSYAL_UK.pdf (page 56, reference 3: TEOXANE International study 2017)
  9. TEOXANE Data on File. TEOSYAL® PURESENSE ULTRA DEEP Notice
  10. TEOXANE Data on File.Teosyal RHA® 3 Notice.
  11. TEOXANE Data on File.Teosyal RHA® 4 Notice.
  12. Luthra A. Shaping lips with fillers. J Cutan Aesthet Surg. 2015;8(3):139-42.

Find a practitioner

Required fields*

I agree to receive exclusive offers and the latest news from Hyaluronic-acid.com
Choose your country

Close

close
Europe

France

UK

Germany

Italy

Poland

Switzerland

International

English

Come back to consumer area

You are switching to our professional universe

close